Fatty Acid Profile and Desaturase Activities in 7-10-Year-Old Children Attending Primary School in Verona South District: Association between Palmitoleic Acid, SCD-16, Indices of Adiposity, and Blood Pressure
- PMID: 32486144
- PMCID: PMC7312303
- DOI: 10.3390/ijms21113899
Fatty Acid Profile and Desaturase Activities in 7-10-Year-Old Children Attending Primary School in Verona South District: Association between Palmitoleic Acid, SCD-16, Indices of Adiposity, and Blood Pressure
Abstract
In previous studies, dietary and circulating fatty acids (FA) and desaturases activity (delta-5 desaturase [D5D], delta-6 desaturase [D6D], and stearoyl-CoA desaturase [SCD-16]) involved in their metabolism were associated with metabolic and cardiovascular disorders. The aim of the study was to assess the association between different FAs and desaturases activity (estimated as product:precursor ratios) with individual cardiovascular risk factors (in particular, anthropometric measurements and blood pressure [BP]) in children. The FA profile was determined on a whole-blood drop in 243 children (age: 8.6 ± 0.72 years) participating in a school-based cross-sectional study. Docosahexaenoic acid (DHA) inversely correlated with indices of adiposity, glucose, and triglycerides. Palmitoleic acid and SCD-16 were directly associated with markers of adiposity and BP, even after adjustment for main confounders. D6D correlated directly with the waist/height ratio. Children with excess weight (>85th percentile; that is overweight plus obese ones) showed higher palmitic acid, palmitoleic acid, and higher SCD-16 activity as compared to normal-weight children. Most of the associations were confirmed in the excess-weight group. Omega-3 FAs, particularly DHA, but not omega-6 FA, showed a potentially beneficial association with metabolic parameters, whereas palmitoleic acid and SCD-16 showed a potentially harmful association with indices of adiposity and BP, especially in obese children.
Keywords: SCD-16; blood pressure; children; desaturase activity; obesity; palmitoleic acid.
Conflict of interest statement
The authors declare no conflict of interest
Figures
References
-
- Bergeron N., Chiu S., Williams P.T., King S., Krauss R.M. Effects of red meat, white meat, and nonmeat protein sources on atherogenic lipoprotein measures in the context of low compared with high saturated fat intake: A randomized controlled trial. Am. J. Clin. Nutr. 2019 doi: 10.1093/ajcn/nqz035. - DOI - PMC - PubMed
-
- Wolfram G., Bechthold A., Boeing H., Ellinger S., Hauner H., Kroke A., Leschik-Bonnet E., Linseisen J., Lorkowski S., Schulze M., et al. Evidence-Based Guideline of the German Nutrition Society: Fat Intake and Prevention of Selected Nutrition-Related Diseases. Ann. Nutr. Metab. 2015;67:141–204. doi: 10.1159/000437243. - DOI - PubMed
-
- Bonafini S., Tagetti A., Gaudino R., Cavarzere P., Montagnana M., Danese E., Benati M., Ramaroli D.A., Raimondi S., Giontella A., et al. Individual fatty acids in erythrocyte membranes are associated with several features of the metabolic syndrome in obese children. Eur. J. Nutr. 2019;58:731–742. doi: 10.1007/s00394-018-1677-2. - DOI - PubMed
-
- Marklund M., Wu J.H.Y., Imamura F., Del Gobbo L.C., Fretts A., de Goede J., Shi P., Tintle N., Wennberg M., Aslibekyan S., et al. Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality. Circulation. 2019;139:2422–2436. doi: 10.1161/CIRCULATIONAHA.118.038908. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
